共 24 条
- [21] Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicityJOURNAL OF APPLIED TOXICOLOGY, 2018, 38 (09) : 1166 - 1176Yang, Xi论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USAPapoian, Thomas论文数: 0 引用数: 0 h-index: 0机构: US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
- [22] Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytesTOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 383Toshikatsu, Matsui论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanKazumasa, Miyamoto论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanKazunori, Yamanaka论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanYoshiko, Okai论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanPfeiffer, Kaushik Emily论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanKousuke, Harada论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanMatthew, Wagoner论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanTadahiro, Shinozawa论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Drug Safety Res & Evaluat, Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan
- [23] Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-CardiomyocytesFRONTIERS IN PHARMACOLOGY, 2019, 10Ribeiro, Alexandre J. S.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAGuth, Brian D.论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Dept Drug Discovery Sci, Biberach, Germany North West Univ, PCDDP, Potchefstroom, South Africa US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAEngwall, Michael论文数: 0 引用数: 0 h-index: 0机构: Amgen Res, Safety Pharmacol & Anim Res Ctr, Thousand Oaks, CA USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAEldridge, Sandy论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAFoley, C. Michael论文数: 0 引用数: 0 h-index: 0机构: AbbVie, Dept Integrat Pharmacol, Integrated Sci & Technol, N Chicago, IL USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAGuo, Liang论文数: 0 引用数: 0 h-index: 0机构: Frederick Natl Lab Canc Res, Lab Invest Toxicol, Frederick, MD USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAGintant, Gary论文数: 0 引用数: 0 h-index: 0机构: AbbVie, Dept Integrat Pharmacol, Integrated Sci & Technol, N Chicago, IL USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAKoerner, John论文数: 0 引用数: 0 h-index: 0机构: US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAParish, Stanley T.论文数: 0 引用数: 0 h-index: 0机构: Hlth & Environm Sci Inst, Washington, DC USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAPierson, Jennifer B.论文数: 0 引用数: 0 h-index: 0机构: Hlth & Environm Sci Inst, Washington, DC USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USABrock, Mathew论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Dept Safety Assessment, San Francisco, CA USA MyoKardia Inc, San Francisco, CA USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAChaudhary, Khuram W.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Plc, Global Safety Pharmacol, Collegeville, PA USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USAKanda, Yasunari论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Hlth Sci, Div Pharmacol, Kawasaki, Kanagawa, Japan US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USABerridge, Brian论文数: 0 引用数: 0 h-index: 0机构: NIEHS, Natl Toxicol Program, POB 12233, Res Triangle Pk, NC 27709 USA US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
- [24] CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical informationREGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 88 : 238 - 251Nozaki, Yumiko论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanHonda, Yayoi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanWatanabe, Hitoshi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanSaiki, Shota论文数: 0 引用数: 0 h-index: 0机构: Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanKoyabu, Kiyotaka论文数: 0 引用数: 0 h-index: 0机构: Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanItoh, Tetsuji论文数: 0 引用数: 0 h-index: 0机构: Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNagasawa, Chiho论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNakamori, Chiaki论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNakayama, Chiaki论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanIwasaki, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Taisho Pharmaceut Co Ltd, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanSuzuki, Shinobu论文数: 0 引用数: 0 h-index: 0机构: Nippon Boehringer Ingelheim Co Ltd, Chuo Ku, 6-7-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanTanaka, Kohji论文数: 0 引用数: 0 h-index: 0机构: Nippon Boehringer Ingelheim Co Ltd, Chuo Ku, 6-7-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanTakahashi, Etsushi论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, 4-1,Shimookui 2 Chome, Toyama 9308508, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanMiyamoto, Kaori论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, 4-1,Shimookui 2 Chome, Toyama 9308508, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanMorimura, Kaoru论文数: 0 引用数: 0 h-index: 0机构: Toyama Chem Co Ltd, Res Labs, 4-1,Shimookui 2 Chome, Toyama 9308508, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanYamanishi, Atsuhiro论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanEndo, Hiroko论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanShinozaki, Junko论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanNogawa, Hisashi论文数: 0 引用数: 0 h-index: 0机构: Kyorin Pharmaceut Co Ltd, Toxicol Res Lab, 1848 Nogi, Nogi, Tochigi 3290114, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanShinozawa, Tadahiro论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Drug Safety Res Labs, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Japan Pharmaceut Mfg Assoc, Nonclin Evaluat Expert Comm, Drug Evaluat Comm, Tokyo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanSaito, Fumiyo论文数: 0 引用数: 0 h-index: 0机构: Chem Evaluat & Res Inst Japan CERI, Chem Assessment & Res Ctr, 1600 Shimotakano, Sugito, Saitama 3450043, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, JapanKunimatsu, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan Consortium Safety Assessment Using Human iPS Cell, Toyonaka, Osaka, Japan Japan Pharmaceut Mfg Assoc, Nonclin Evaluat Expert Comm, Drug Evaluat Comm, Tokyo, Japan Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan